Wikidata

(Q46869499)

English

A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury

scientific article published in December 2005

In more languages

Statements

title
A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16379582
retrieved
26 December 2017
reference URL
http://europepmc.org/abstract/MED/16379582
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46869499&oldid=2135348155"